Insider plans sale of 480,724 GM shares

An unnamed General Motors (GM) shareholder filed a notice of proposed sale under Rule 144 for up to 480,724 common shares, with an aggregate market value of $38,977,101.92, to be sold through Morgan Stanley Smith Barney LLC on the NYSE around 02/17/2026.

Accepted by SEC EDGAR 02/17/2026 - 04:40 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

An unnamed General Motors (GM) shareholder filed a notice of proposed sale under Rule 144 for up to 480,724 common shares, with an aggregate market value of $38,977,101.92, to be sold through Morgan Stanley Smith Barney LLC on the NYSE around 02/17/2026.

The filing shows that 230,058 shares were acquired on 02/17/2026 through a cash exercise of stock options, and 250,666 shares were acquired on 02/12/2023 via performance stock units. GM common shares outstanding were 903,967,853, a baseline figure for context.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the GM Form 144 filing disclose about planned share sales?

The Form 144 reports a planned sale of up to 480,724 GM common shares with an aggregate market value of $38,977,101.92. These shares are expected to be sold on the NYSE through Morgan Stanley Smith Barney LLC around 02/17/2026.

How many GM shares are outstanding compared with the Form 144 sale?

The filing lists 903,967,853 GM common shares outstanding, providing a baseline for context. The planned sale covers 480,724 shares, a relatively small portion of the total, and represents only the position of the filing shareholder, not the entire market.

How were the GM shares in this Form 144 acquired by the seller?

The notice shows two acquisition sources: 230,058 shares obtained on 02/17/2026 via a cash exercise of stock options, and 250,666 shares acquired on 02/12/2023 through performance stock units granted by the issuer, General Motors.

Which broker will handle the GM shares sale disclosed in the Form 144?

The filing identifies Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, as the broker. The GM common shares are expected to be sold on the NYSE under this arrangement.

What is the approximate sale date for the GM shares in this Form 144?

The Form 144 lists an approximate date of sale of 02/17/2026 for the 480,724 GM common shares. This date represents when the shareholder expects to begin selling the shares on the NYSE through the designated broker.

Does the GM Form 144 mention any recent sales by this shareholder?

The document provides a section for securities sold during the past 3 months, but the excerpt does not list any completed transactions there. The main detail is the proposed sale of 480,724 GM common shares going forward.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001492362
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	GENERAL MOTORS COMPANY
SEC File Number	001-34960
Address of Issuer	1240 Woodward Avenue Detroit MICHIGAN 48265
Phone	3136671500
Name of Person for Whose Account the Securities are To Be Sold	MARK L REUSS
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	480724	38977101.92	903967853	02/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/17/2026	Exercise of Stock Options	Issuer			230058	02/17/2026	Cash
Common	02/12/2023	Performance Stock Units	Issuer			250666	02/12/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities to be sold were or will be acquired upon the vesting of performance stock units during the period of 02/12/2023 through 02/07/2026.
Date of Notice	02/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/17/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Mark L Reuss
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)